Cargando…
25: Seroprevalence and clinical characteristics of SARS-CoV-2 infection in children and adolescents with cystic fibrosis
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Cystic Fibrosis Society.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518463/ http://dx.doi.org/10.1016/S1569-1993(21)01450-8 |
| _version_ | 1784584229276876800 |
|---|---|
| author | Hergenroeder, G. Cogen, J. Genatossio, A. McNamara, S. Pascual, M. Hernandez, R. |
| author_facet | Hergenroeder, G. Cogen, J. Genatossio, A. McNamara, S. Pascual, M. Hernandez, R. |
| author_sort | Hergenroeder, G. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8518463 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | European Cystic Fibrosis Society. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85184632021-10-15 25: Seroprevalence and clinical characteristics of SARS-CoV-2 infection in children and adolescents with cystic fibrosis Hergenroeder, G. Cogen, J. Genatossio, A. McNamara, S. Pascual, M. Hernandez, R. J Cyst Fibros Posters European Cystic Fibrosis Society. 2021-11 2021-10-15 /pmc/articles/PMC8518463/ http://dx.doi.org/10.1016/S1569-1993(21)01450-8 Text en Copyright © 2021 European Cystic Fibrosis Society. All rights reserved. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Posters Hergenroeder, G. Cogen, J. Genatossio, A. McNamara, S. Pascual, M. Hernandez, R. 25: Seroprevalence and clinical characteristics of SARS-CoV-2 infection in children and adolescents with cystic fibrosis |
| title | 25: Seroprevalence and clinical characteristics of SARS-CoV-2 infection in children and adolescents with cystic fibrosis |
| title_full | 25: Seroprevalence and clinical characteristics of SARS-CoV-2 infection in children and adolescents with cystic fibrosis |
| title_fullStr | 25: Seroprevalence and clinical characteristics of SARS-CoV-2 infection in children and adolescents with cystic fibrosis |
| title_full_unstemmed | 25: Seroprevalence and clinical characteristics of SARS-CoV-2 infection in children and adolescents with cystic fibrosis |
| title_short | 25: Seroprevalence and clinical characteristics of SARS-CoV-2 infection in children and adolescents with cystic fibrosis |
| title_sort | 25: seroprevalence and clinical characteristics of sars-cov-2 infection in children and adolescents with cystic fibrosis |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518463/ http://dx.doi.org/10.1016/S1569-1993(21)01450-8 |
| work_keys_str_mv | AT hergenroederg 25seroprevalenceandclinicalcharacteristicsofsarscov2infectioninchildrenandadolescentswithcysticfibrosis AT cogenj 25seroprevalenceandclinicalcharacteristicsofsarscov2infectioninchildrenandadolescentswithcysticfibrosis AT genatossioa 25seroprevalenceandclinicalcharacteristicsofsarscov2infectioninchildrenandadolescentswithcysticfibrosis AT mcnamaras 25seroprevalenceandclinicalcharacteristicsofsarscov2infectioninchildrenandadolescentswithcysticfibrosis AT pascualm 25seroprevalenceandclinicalcharacteristicsofsarscov2infectioninchildrenandadolescentswithcysticfibrosis AT hernandezr 25seroprevalenceandclinicalcharacteristicsofsarscov2infectioninchildrenandadolescentswithcysticfibrosis |